FDA Investigator Nicholas S Vasilakes
Nicholas S Vasilakes has inspections in 2 countries as of 05 Oct 2023. Nicholas S Vasilakes has collaborated with a combined 1331 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
101
Last Inspection Date:
05 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Madagascar
Co-Investigator(s):
Aaron L Dunbar,
Alecia L Marson,
Amanda J Ney,
Amir Alavi,
Amos,
Amy L Mcintyre,
Boun M Xiong,
Brian L Szcyubialka,
Brian R Yaun,
Carolyn A Warren,
Catherine M Vanderhoef,
Charles R Cote, RIC,
Christina A Castineyra,
Como,
Courtney R Ingalsbe,
Courtney R Tiegs,
Craig R Berger,
Darren D Holaday,
Demetria L Lueneburg,
Diane T Reindl,
Elias H Wachter,
Ellen C Weisensel,
Eric A Breselow,
Grant M Ruis,
Heather Akleimola Hulbert,
Heidi J Debeck,
Howard A Burmester,
Jacob W Reynolds,
Jamie R Thompson,
Jasjeet K Sekhon,
Jean M Bosenbecker,
Jeffry A Bernhardt,
Jennifer Guttuso,
Jesse P Romenesko,
Joel D Hustedt,
Jon C Polzine,
Justin A Boyd,
Justin J Jafferis,
Kailas Nagaraj,
Karen M Labounty,
Katherine A Clarke Girolamo,
Kathryn M Mogen,
Kenneth A Libertoski,
Kimberly W Destromp,
Leon R Stratman,
Linda V Weyer,
Lisa M Lopez,
Mada A Tautges,
Mary Ann Ruff,
Melanie C Voges,
Mohammed H Adam,
Natalie E Starczowski,
Nicholas J Dubrovin,
Paola E Lathrop,
Patricia A Holmstrom,
Peter T Erlandson,
Rebecca L Caulfield,
Rebecca L Mullikin,
Richard Jay Tucker, RS,
Ronald R Ruff,
Sandra D Wilson,
Sandra D Wilson Newby,
Sarah A Palmer,
Scott B Laufenberg,
State Agency,
Susan M Miller,
Suzanne M Crotty,
Tanya L Keigley,
Tara M Carolfi,
Theresa C Klaman,
Thomas S Donaldson,
Tyson J Eldridge Stedman,
William E Keer,
William P Fournier
Nicholas S Vasilakes's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2023 | FDA 483 | DSM Nutritional Products LLC - Form 483, 2023-05-19 |
January, 2024 | FDA 483 | Nippon Express U.S.A., Inc. - Form 483, 2024-01-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more